Literature DB >> 10419449

E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities.

R Shao1, M C Hu, B P Zhou, S Y Lin, P J Chiao, R H von Lindern, B Spohn, M C Hung.   

Abstract

The adenovirus E1A protein has been implicated in increasing cellular susceptibility to apoptosis induced by tumor necrosis factor (TNF); however, its mechanism of action is still unknown. Since activation of nuclear factor kappaB (NF-kappaB) has been shown to play an anti-apoptotic role in TNF-induced apoptosis, we examined apoptotic susceptibility and NF-kappaB activation induced by TNF in the E1A transfectants and their parental cells. Here, we reported that E1A inhibited activation of NF-kappaB and rendered cells more sensitive to TNF-induced apoptosis. We further showed that this inhibition was through suppression of IkappaB kinase (IKK) activity and IkappaB phosphorylation. Moreover, deletion of the p300 and Rb binding domains of E1A abolished its function in blocking IKK activity and IkappaB phosphorylation, suggesting that these domains are essential for the E1A function in down-regulating IKK activity and NF-kappaB signaling. However, the role of E1A in inhibiting IKK activity might be indirect. Nevertheless, our results suggest that inhibition of IKK activity by E1A is an important mechanism for the E1A-mediated sensitization of TNF-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419449     DOI: 10.1074/jbc.274.31.21495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

Authors:  Jen-Liang Su; Xiaoyun Cheng; Hirohito Yamaguchi; Yi-Wen Chang; Chao-Feng Hou; Dung-Fang Lee; How-Wen Ko; Kuo-Tai Hua; Ying-Nai Wang; Michael Hsiao; Poshen B Chen; Jung-Mao Hsu; Robert C Bast; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2011-09-12       Impact factor: 12.701

3.  Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.

Authors:  John M Routes; Kristin Morris; Misoo C Ellison; Sharon Ryan
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis.

Authors:  P Clarke; R L Debiasi; S M Meintzer; B A Robinson; K L Tyler
Journal:  Apoptosis       Date:  2005-05       Impact factor: 4.677

5.  Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex.

Authors:  Joshua M Friedman; Marshall S Horwitz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity.

Authors:  W P Lee; Y Liao; D Robinson; H J Kung; E T Liu; M C Hung
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase.

Authors:  Soo-Ho Choi; Kyu-Jin Park; Byung-Yoon Ahn; Guhung Jung; Michael M C Lai; Soon B Hwang
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells.

Authors:  Ryosuke Inoue; Nori-aki Matsuki; Gao Jing; Takashi Kanematsu; Kihachiro Abe; Masato Hirata
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

9.  E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S.

Authors:  Denise Perez; Eileen White
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Advances in targeting IKK and IKK-related kinases for cancer therapy.

Authors:  Dung-Fang Lee; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.